Eric Dobmeier, JD

Eric joined Samsara BioCapital as a Venture Partner in 2024. He brings over two decades of leadership, operating and business development experience in the industry. Prior to being President and CEO of Chinook, Eric was President and CEO of Silverback Therapeutics, which was focused in the immuno-oncology space. Prior to that, Eric spent more than 15 years at Seattle Genetics, most recently as Chief Operating Officer, where he oversaw business development, corporate communications, manufacturing, program/alliance management activities and corporate strategy initiatives. While at Seattle Genetics, Eric was also directly involved in raising more than $1.2 billion in equity capital and led negotiation and completion of multiple corporate alliances with leading biotechnology and pharmaceutical companies. Earlier in his career, he represented technology companies in connection with public and private financings, mergers and acquisitions and corporate partnering transactions.